University of North Carolina, Charlotte   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Charlotte NC United States (1946)

Organization Overview

First Clinical Trial
2006
NCT00329797
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Antoinette Tan, MD | Arielle Heeke | Carolinas Medical Center - University | Daniel Carrizosa | Department of Pediatrics, Levine Children's Hospital, Carolinas Healthcare System | Jai Patel | Jamie Mochel | Justin Arnall | Levine Children’s Hospital | Levine Children's Hospital at Carolinas HealthCare System | Mohamed Salem | Shebli Atrash | UNC Charlotte | University of North Carolina, Charlotte

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cholestasis (Phase 2)

Immunologic Deficiency Syndromes (Phase 2)

Osteoporosis (Phase 3)

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 21